AMERIPRISE FINANCIAL INC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 148 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,138,000
-10.1%
82,720
+3.6%
0.00%
Q1 2022$1,266,000
-27.4%
79,865
-0.1%
0.00%
Q4 2021$1,744,000
-18.2%
79,905
+12.0%
0.00%
-100.0%
Q3 2021$2,133,000
-35.0%
71,355
-3.7%
0.00%0.0%
Q2 2021$3,283,000
+49.3%
74,130
+49.6%
0.00%0.0%
Q1 2021$2,199,000
-24.7%
49,562
-6.9%
0.00%0.0%
Q4 2020$2,919,00053,2410.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders